HomeUncategorizedFDA authorizes marketing of Zika diagnostic test

FDA authorizes marketing of Zika diagnostic test


On May 23, the FDA authorized marketing of ZIKV Detect 2.0 IgM Capture ELISA, the first diagnostic test for detecting Zika virus immunoglobulin antibodies in human blood.

Read more at fda.gov.


Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Couple talking to NP

Getting Covid Vaccine Won’t Hurt Pregnancy Chances; Getting Covid Could

Couples planning a pregnancy might be relieved to know that getting a Covid vaccine does not hurt their odds of conceiving, according to the...